Metabolic Phenotyping and Seahorse Analysis Service
Assay menu
| Assay | Injections | Reports | Typical use |
|---|---|---|---|
| Mito Stress Test | Oligomycin, FCCP, rotenone/antimycin A | Basal, ATP-linked, maximal, spare capacity, proton leak | Mitochondrial function |
| Glycolysis Stress Test | Glucose, oligomycin, 2-DG | Basal acidification, glycolytic capacity, reserve | Glycolytic response |
| ATP Rate Assay | Oligomycin plus rotenone/antimycin A | Mitochondrial and glycolytic ATP production rates | ATP source split |
| Substrate oxidation | Etomoxir or BPTES plus uncoupler | Fatty acid and glutamine dependence of respiration | Substrate preference |
| Real-time sampling | None | Glucose, lactate, glutamine in medium over time | Net exchange |
Important distinction. The Glycolysis Stress Test reports extracellular acidification, not glycolytic rate. Acidification includes a respiratory CO₂ contribution, so the "glycolytic" parameters are conditional. We report the raw ECAR values alongside the derived parameters, and we recommend lactate measurement when the claim is about glycolysis itself.
Sample types and what each requires
| Sample | Requirement | Constraint |
|---|---|---|
| Adherent cells | 70–90% confluence, even seeding | Edge effects; density-dependent baseline |
| Suspension cells | Immobilisation with Cell-Tak or matrix | The coating is a variable; report it |
| Spheroids | Size-matched, 300–500 µm | The measured rate includes a diffusion gradient |
| Isolated mitochondria | Fresh, protein-quantified | Not comparable to intact-cell rates |
| Permeabilised cells | Digitonin titration | The permeabilisation itself must be validated |
The third row is the one where clients most often expect more than the assay can give: a spheroid value is an average over a hypoxic core and a normoxic rim, and we report size distribution with the result.
Normalisation
| Option | When we use it | Caveat |
|---|---|---|
| Cell count at assay end | Default | Requires a terminal count in the same well |
| DNA content | Proliferating cells, variable size | Sensitive to cell-cycle shift |
| Protein | Only where protein per cell is stable | Moves with lipid loading and activation |
| Citrate synthase activity | Mitochondrial content correction | Separates "more organelles" from "better organelles" |
We report the primary rate per well, then the normalised value, then the normalisation method. A rate without a stated denominator is not comparable across conditions, and most published discrepancies come from this step rather than from the measurement.
What you receive
- • Raw OCR and ECAR per well, with the injection log and timestamps.
- • Derived parameters, each with the assumption used in its calculation stated in a footnote.
- • Terminal normalisation data for every well.
- • A plate map, the assay medium composition, and the raw instrument file.
- • A short note on anything that failed QC, including wells excluded and why.
What we do not do
- • Report a glycolytic rate from ECAR alone. We report acidification and say so.
- • Report maximal respiration without an FCCP titration for the cell type and day.
- • Compare plates without a bridge sample. Instrument and plate variability is real; a bridge condition on each plate is the control.
- • Infer dependency from a rate. A higher OCR is a rate, not a requirement; that needs a restriction experiment.
Turnaround
| Stage | Working days |
|---|---|
| Cell expansion and QC | 5–10 (client-dependent) |
| Assay optimisation (first time in a new background) | 5–10 |
| Assay run and analysis | 3–5 per plate set |
Typical project: 3–5 weeks from receipt of cells, including a titration plate.
What we need from you
- Cell type, passage, medium and mycoplasma status.
- The question, in one sentence — a rate question and a dependency question need different plates.
- Whether the readout must be per cell or per mitochondrial content.
- The treatments and their timing relative to the assay.
Where this connects
- • Glucose pillar supplies the ECAR and OCR interpretation rules this service follows.
- • Mitochondrial pillar supplies the derived-parameter assumptions.
- • The self-assessment scores the readout type; if that row is low, an assay on this menu will not fix it, and we will say so before quoting.
Selected references for further reading
- • Mookerjee SA, Gerencser AA, Nicholls DG, Brand MD. Quantifying intracellular rates of glycolytic and oxidative ATP production. Journal of Biological Chemistry. 2017;292:7189–7207.
- • Divakaruni AS, Jastroch M. A practical guide for the analysis, standardization and interpretation of oxygen consumption measurements. Nature Metabolism. 2022;4:978–994.
- • Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochemical Journal. 2011;435:297–312.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PBRM1 Knockout A-549 Cell Line | EDJ0001-K01 | Human | 55193 | Details Get a Quote |
| YTHDC1 Knockout A-549 Cell Line | EDC07652 | Human | 91746 | Details Get a Quote |
| TP53 Knockout HCT 116 Cell Line | EDC07854 | Human | 7157 | Details Get a Quote |
| Sirt2 Knockout MH-S Cell Line | EDJ-KQ78173 | Mouse | 64383 | Details Get a Quote |
| TFE3 Knockout KGN Cell Line | EDJ-KQ48 | Human | 7030 | Details Get a Quote |
| Stub1 Knockout MB49 Cell Line | EDJ-KQ53 | Mouse | 56424 | Details Get a Quote |
| ARID1A Knockout SNK-6 Cell Line | EDJ-KQ64 | Human | 8289 | Details Get a Quote |
| Tet1 Knockout Kupffer Cell Line | EDJ-KQ88 | Mouse | 52463 | Details Get a Quote |
| NR1H3 Knockout HEK293T Cell Line | EDJ-KQ109 | Human | 10062 | Details Get a Quote |
| NR1H2 Knockout HEK293T Cell Line | EDJ-KQ110 | Human | 7376 | Details Get a Quote |
| RPS6KB2 Knockout HEK293 Cell Line | EDJ-KQ125 | Human | 6199 | Details Get a Quote |
| SMAD6 Knockout HEK293 Cell Line | EDJ-KQ126 | Human | 4091 | Details Get a Quote |
| JUN Knockout HEK293 Cell Line | EDJ-KQ176 | Human | 3725 | Details Get a Quote |
| JUN Knockout HEK293T Cell Line | EDJ-KQ184 | Human | 3725 | Details Get a Quote |
| ALKBH5 Knockout HEK293 Cell Line | EDJ-KQ186 | Human | 54890 | Details Get a Quote |
- 1
- 2
- ...
- Next Page »